Thoracic Flashcards
EGFR mutation (lung ca)
More common in non smokers, adenoCA
Erlotinib or other TK inhibitor has benefit in advanced stage NSCLC and is first line if EGFR mutation present
Adjuvant therapy after surgery is still platinum based chemo for resectable disease
Approach for distal trachea/carina/prox main branches
Right posterolateral thoracotomy
Approach to Distal left main stem
Left posterolateral thoracotomy
Barrett’s esophagus
Result of long standing GERD
Salmon colored on EGD
Screening indicated for men with GERD and another risk factor.
Need to make dx histologically with Seattle protocol - sampling 4 quadrants every cm. Looking for low or high grade dysplasia or early cancer
Treat HGD with endoscopic mucosal resection but avoid circumferential which causes stricture
If mucosal involvement of CA needs esophagectomy unless very superficial
Followup screening 1,3,6 months and yearly for HGD. Follow up annually for LGD
Radiofreq ablation is indicated for remaining Barrett’s after resection of HGD lesion
Best marker for esophagogastric junction
Important to make sure wrap is in the right place
Ruggal folds of stomach demarcate transition
Gastric fat pad is very variable and can’t be used
Infected in dwelling pleural drainage in setting of malignant pleural effusion
90% resolve with antibiotics
Open drainage and packing is most definitive source control but most can just treat w abx
Hamartoma
Lobulated nodule with fat and popcorn calcification
Benign
Just observation and resect if any growth
Usually peripheral, lower lung fields
Carcinoid tumor features
Round or lobulated. Smooth. Non calcified, no fat.
Usually central/assocaited with bronchus (airway compromise often initial Presentation)
Bimodal presentation (older more likely atypical)
Typical <2 mitotic figures
Atypical 2-10 mitotic figures with necrosis
If no nodal disease on clinical staging, no need to do LN sampling (proceed to resection) but if positive nodes on clinical staging, should get tissue.
Lung cancer on imaging
Often spiculated
Solid, non solid or ground glass features possible
Usually non calcified but if it is then it’s eccentric calcium. (Calcified granuloma often has central calcification and associated calcified LN)
Leiomyoma of esophagus
Rare but this is most common submucosal benign lesion
Occur in Distal esophagus
Benign but should rule out GiST with FNA
Smooth bulging see on endo
Observation for small asymptomatic or vats/lap enucleation if large/symptoms (dysphagia)
Endoscopic mucosal resection can lead to full thickness defect if lesion is more than 2cm
Avoid messing up sphincter in which case an anti reflux procedure is indicated
Sarcoidosis
More common in AA
Non caseating granulomas
Diffuse interstitial process in upper lobes
Hilar/mediastinal Adenopathy common and sampling these nodes provides dx
Endoscopic ultrasound guided needle biopsy best approach
Mediastinoscopy could sample nodes but higher risk
Many improve without treatment but 20% progress.
Steroids first line
Tracheal release maneuvers
Neck flex room/guardian stitch gives 4cm
Suprahyoid release (horiz incision in neck crease) has supplanted laryngeal release for upper tracheal lengthening (buys 1-2cm). Laryngeal release risks nerve/artery damage
Hilar and pericardial release for Lower trachea (usually right thoracotomy). Incise pericardium with U shaped incision around pulmonary vein (ant/post/inferior U). Phrenic nerve injury is key risk. Divide pulmonary ligament to help exposure
Adenoid cystic carcinoma (ACC)
Second most common tracheal tumor (first is SCC)
Try for Ro resection but often spreads along lymphatics and submucosa. If residual margin, should get radiation.
Chemo for metastatic disease/recurrence
PTLD
Post transplant lymphoprolif disease
3-8% post lung txp
Associated w EBV in donor
B cell expansion
Early lesion treated with reducing immunosuppression (as tolerated w rejection) and rituximab if cd20 positive
Good response if early lesion
Toupet fundoplication
Partial wrap - (270) better if there is ineffective peristalsis
Nissen
Full wrap
Esophageal duplication cyst
Usually doesn’t communicate with esophagus
Surgical resection if symptoms (not drainage or marsupialization)
Locally advanced esophageal cancer (T3) treatment (2b-3c)
Definitive chemoradiation vs chemorad followed by esophagectomy are equivalent outcomes. So no surgery generally
Mediastinal nonseminomatous germ cell tumor treatment
Tx - systemic chemo (bleo/etoposide/cisplatin)
Tumors are chemo sensitive but there will be residual mass that needs resection
Esophageal adeno demographics
M>F 6 fold
Advanced age biggest risk factor
Smoking NC increases risk (2 fold) but not as much as for SCC
Obesity (BMI>30 has 2 fold risk compared to less than 25)
Treatment for metastatic esophageal ca
5FU-Cisplatin (add 3d agent if medically fit)
HER2 testing indicated for metastatic. Trastuzamab indicated if HER2 is over expressed
Keynote 590 - adding pembromizulab (PD1) has survival advantage in sCC and adeno
Lung abscess in alcoholic
Actinomyces- facultative anaerobe
4-6 weeks IV penicillin then oral 6-12 weeks
Dx: flex bronch +/- transthoracic needle biopsy
Thymic Ca TNM
T1 - does not invade neighboring structures
T2 - Pericardial invasion
T3 - adjacent structures (lung/SVC,phrenic)
T4 - Aorta/heart invasion (non resectable)
N1 0 anterior perithymic nodes
N2 - outside perithymic area (cervical or supraclavicular)
Fibrosing Mediastinitis
Unclear pathophysiology.
Histoplasma capaulatum may be underlying cause setting off a hyper immune response
Leads to inflammation and calcified lesions throughout mediastinum. Causes airway and vascular (PA) compression. No good treatment but stenting palliative
Stereotactic ablative radiotherapy
Used for both SCC and adeno tumors that are medically inoperable
High risk if preexisting fibrosis exists
Minimally invasive adeno carcinoma
Rare type of NSCLC
Lepidic growth (grows in air spaces). Less than 5mm of an invasive component
Surgery alone, no additional treatment necessary
100% cure
Chicago classification
Type 1 achalasia - Absent peristalsis and negligible pressurization in the esophagus (mostly blue)
Type 2 - absent peristalis and pan-esophageal pressurization (mostly green). Best treatment response
Type 3 - spastic type - rapidly propagating or spastic simulatneous contractions, involve at least 20%. Worst treatment response
Integrated relaxing pressure
LES
Should be below 15 if normal. High in achalasia
Achalasia tx
Heller myotomy most effective
Baloon dilation, less long term effective but option of non op
Botox injection if above not possible.
Malignant TE fistula
erosion by mass and radiation can cause communication
Esophageal stent is favored method of paliation. Placing tracheal stent as well can cause necrosis.
Gastric outlet obstruction following esophagectomy
Endoscopy to inspect pylorius and baloon dilitation if it’s tight. Dont use botox
Cervical mediastinoscopy nodes
2,4,7 (defines N2 or N3).
Subcarinal (N2)
Ipsilateral 2/4 (N2)
Contra lateral 2/4 (N3)
prediceted postop FEV1 and DLCO cutoffs
<40% high risk
<20% inoperable
Factors that are high/projbitive surgery risk
VO2<10ml/kg/min are prohibitive risk and most important determinant
predicted FEV1<0.8L or <40% predicted
FVC<1.5L or <30% predicted
FEV1/FVC<50%
Resting pO2<45
Resting pCO2>50
Genetic mutation cancer associations (kras, EGFR,cMyc)
K ras - worse prognosis in NSCLC
EGFR - adenocarcinoma in smoker and nmon smokers. Respond to TK inhibitors
c-Myc - linked to SCLC